Atorvastatin (Compound)

Synonyms:atorvastatin, 134523-00-5, Cardyl, Lipitor, Torvast, ATORVASTATIN CALCIUM, UNII-A0JWA85V8F, (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid, 110862-48-1, CI 981, Lipitor (TN), Tozalip, Xavator, A0JWA85V8F, CHEMBL1487, (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid, CHEBI:39548, (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, 134523-03-8, Atorvastatin [INN:BAN], 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R-(R*,R*))-, 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID, Atorvastatin calcium salt, atorvastatina, atorvastatine, atrovastin, Atofast, Atorcor, Atorlip, Lipilou, Lipinon, Atorin, Ator, Lipitor(TM), (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid, (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, Atorvastatin (INN), Sortis (TN), CCRIS 7159, MFCD00899261, C33H35FN2O5, HSDB 7039, NCGC00159458-03, atorvastatinum, rel-Atorvastatin, (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid, Atorvastatin & Primycin, DSSTox_CID_9868, SCHEMBL3831, DSSTox_RID_78825, DSSTox_GSID_29868, BIDD:GT0336, Atorvastatin (Relative Stereo), GTPL2949, DTXSID8029868, BDBM22164, DTXSID60274003, HMS3715L05, HMS3886C20, Lipilou; Tozalip; Torvast; Cardyl, (3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, ACT03225, HY-B0589, ZINC3920719, Tox21_302417, s5715, AKOS000281127, AC-9386, CCG-221172, DB01076, MCULE-2368532812, MRF-0000761, NCGC00159458-02, NCGC00159458-20, NCGC00255181-01, (3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaR,deltaR)-, 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID, AS-35260, H942, CAS-134523-00-5, C06834, D07474, 28052-EP2269989A1, 28052-EP2269990A1, 28052-EP2270011A1, 28052-EP2270505A1, 28052-EP2272825A2, 28052-EP2272841A1, 28052-EP2280001A1, 28052-EP2284158A1, 28052-EP2287165A2, 28052-EP2287166A2, 28052-EP2292600A1, 28052-EP2292620A2, 28052-EP2295406A1, 28052-EP2295409A1, 28052-EP2295417A1
Pubchem:PUBCHEM:60823
Id:60823
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Atorvastatin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Atorvastatin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Atorvastatin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.